Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug ...
Adial Pharmaceuticals, Inc. announced the issuance of patent 12150931, covering a broader range of genotype combinations for the treatment of alcohol use disorder with AD04, expanding its IP protection through 2031.
Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded ...
Adial Pharmaceuticals receives Notice of Allowance for U.S. patent expanding IP protection for AD04, covering additional genotype combinations via proprietary genetic diagnostic tool, enhancing precision medicine approach for alcohol use disorder treatment.
© Copyright 2024. All Rights Reserved by MedPath